NECOX
Price
$21.28
Change
-$0.10 (-0.47%)
Updated
Jun 18 closing price
Net Assets
913.45M
RMFCX
Price
$62.40
Change
+$0.29 (+0.47%)
Updated
Jun 18 closing price
Net Assets
116.64B
Interact to see
Advertisement

NECOX vs RMFCX

NECOX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
NECOX vs. RMFCX commentary
Jun 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NECOX is a Hold and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 117B vs. NECOX (913M). RMFCX pays higher dividends than NECOX: RMFCX (1.19) vs NECOX (0.33). NECOX was incepted earlier than RMFCX: NECOX (31 years) vs RMFCX (24 years). NECOX (1.81) is less costly to investors than RMFCX (0.91). NECOX is a more actively managed with annual turnover of: 53.00 vs. RMFCX (30.00). RMFCX has a lower initial minimum investment than NECOX: RMFCX (250) vs NECOX (2500). RMFCX annual gain was more profitable for investors over the last year : 9.83 vs. NECOX (-3.25). RMFCX return over 5 years is better than : 37.65 vs. NECOX (-6.92).
NECOXRMFCXNECOX / RMFCX
Total Expense Ratio1.780.91196%
Annual Report Gross Expense Ratio1.810.91199%
Fund Existence31 years24 years-
Gain YTD-7.3666.180-119%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets913M117B1%
Annual Yield % from dividends0.331.1928%
Returns for 1 year-3.259.83-33%
Returns for 3 years10.8432.4733%
Returns for 5 years-6.9237.65-18%
Returns for 10 years33.6393.7036%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IAFLX21.92-0.18
-0.81%
F/m Investments Large Cap Focused Inst
FDNRX189.89-1.70
-0.89%
Franklin DynaTech R
CDEYX20.91-0.20
-0.95%
Columbia Intrinsic Value Institutional 3
GRINX24.79-0.24
-0.96%
Victory Diversified Stock R
GSUSX53.27-0.69
-1.28%
Goldman Sachs US Equity Insights C